Wild, D. (2011) Glucagon-like peptide-1 receptor imaging probes translation of molecular biology into clinical application including insulinoma and islet cell imaging. Doctoral thesis, UCL (University College London).
Full text not available from this repository.
Strong over-expression of Glucagon-like Peptide-1 receptors (GLP-1-R) in human pancreatic β cells and in insulinoma provide an attractive target for imaging. This is relevant since the preoperative localisation of insulinomas remains a challenge whilst serial measurements of functional β cell mass (BCM) may improve monitoring of novel diabetes therapies such as islet cell replacement. The aim of the thesis was to develop and evaluate GLP-1-R imaging probes and translate these into clinical applications, including insulinoma and β cell imaging. After extensive preclinical evaluation (internalization, externalization, biodistribution, pharmacokinetic, imaging and detailed dosimetry studies) of different GLP-1-R imaging tracers, the most promising probe, [Lys40(Ahx-DOTA-111In)NH2]-exendin-4, was selected for a first in man study. This novel probe was then prospectively evaluated in the management setting of benign and malignant insulinoma. An additional proof of concept study was performed in a patient after intramuscular transplantation of islet cells. The GLP-1-R planar imaging study showed focally raised tracer uptake in functional β cells transplanted into the brachioradialis muscle of a 48 years old woman. In patients with benign insulinomas GLP-1-R imaging was superior to conventional imaging (CT, MRI, somatostatin receptor imaging and endoscopic ultrasound) and detected the insulinoma in all 6 patients pre- and intra-operatively. This is in contrast to patients with malignant insulinoma where conventional imaging (CT and somatostatin receptor imaging) was superior to GLP-1-R imaging, which detected the primary tumour and metastases in only 4/11 patients. In conclusion, these data, based on the development and evaluation of a novel probe, strongly suggest that GLP-1-R imaging offers a new approach to localise benign insulinomas. With further refinements of the labelling agent and the imaging methodology, it is expected that GLP-1-R imaging may have the potential for non-invasive imaging of pancreatic islets and the early diagnosis of β cell graft rejection. This thesis has led to six original publications and one review article. These are listed at the end of each chapter. For a full list please see appendix.
|Title:||Glucagon-like peptide-1 receptor imaging probes translation of molecular biology into clinical application including insulinoma and islet cell imaging|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)|
Archive Staff Only: edit this record